With five products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.
- Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin... MORE >
- BioMarin Receives Rare Pediatric Disease Designation From FDA for Drisapersen for the Potential Treatment of Duchenne Muscular Dystrophy... MORE >
- Forbes Ranks BioMarin 10th Most Innovative Company in the World... MORE >
- /> Click here to learn more about VIMIZIM (elosulfase alfa), including full prescribing information and boxed warning.
- /> MorquioAnswers.com is an educational site for health care professionals to learn more about Morquio A diagnosis and management.
- Morquiosity.com is designed to empower the Morquio A community through education and support.
- PKU.com is a comprehensive online resource for the PKU community.